These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35287261)

  • 21. [VALIDATION OF THE HUNGARIAN UNIFIED DYSKINESIA RATING SCALE].
    Horváth K; Aschermann Z; Ács P; Bosnyák E; Deli G; Pál E; Késmárki I; Horvath R; Takacs K; Balázs E; Komoly S; Bokor M; Rigó E; Lajtos J; Takáts A; Tóth A; Klivényi P; Dibó G; Vecsei L; Hidasi E; Nagy F; Herceg M; Imre P; Kovács N
    Ideggyogy Sz; 2015 May; 68(5-6):183-8. PubMed ID: 26182609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calibration of unified Parkinson's disease rating scale scores to Movement Disorder Society-unified Parkinson's disease rating scale scores.
    Goetz CG; Stebbins GT; Tilley BC
    Mov Disord; 2012 Sep; 27(10):1239-42. PubMed ID: 22886777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using Movement Disorder Society Unified Parkinson's Disease Rating Scale Parts 2 and 3 Simultaneously: Combining the Patient Voice with Clinician Ratings.
    Guo Y; Goetz CG; Stebbins GT; Mestre TA; Luo S
    Mov Disord; 2023 Mar; 38(3):453-463. PubMed ID: 36621935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of the Polish version of the Unified Dyskinesia Rating Scale (UDysRS).
    Siuda J; Boczarska-Jedynak M; Budrewicz S; Dulski J; Figura M; Fiszer U; Gajos A; Gorzkowska A; Koziorowska-Gawron E; Koziorowski D; Krygowska-Wajs A; Rudzińska-Bar M; Sławek J; Toś M; Wójcik-Pędziwiatr M; Lin J; Luo S; Martinez-Martin P; Stebbins GT; Goetz CG; Opala G;
    Neurol Neurochir Pol; 2021; 55(2):186-194. PubMed ID: 33528833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of the Finnish Version of the Unified Dyskinesia Rating Scale.
    Kaasinen V; Scheperjans F; Kärppä M; Korpela J; Brück A; Sipilä JOT; Joutsa J; Järvelä J; Eerola-Rautio J; Martikainen MH; Airaksinen K; Stebbins GT; Martinez-Martin P; Goetz CG; Lin J; Luo S; Pekkonen E
    Eur Neurol; 2021; 84(6):444-449. PubMed ID: 34261060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Item Response Model Adaptation for Analyzing Data from Different Versions of Parkinson's Disease Rating Scales.
    Gottipati G; Berges AC; Yang S; Chen C; Karlsson MO; Plan EL
    Pharm Res; 2019 Jul; 36(9):135. PubMed ID: 31317279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationships among cognitive impairment, sleep, and fatigue in Parkinson's disease using the MDS-UPDRS.
    Goldman JG; Stebbins GT; Leung V; Tilley BC; Goetz CG
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1135-9. PubMed ID: 25150770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. It Is as It Was: MDS-UPDRS Part III Scores Cannot Be Combined with Other Parts to Give a Valid Sum.
    Goetz CG; Choi D; Guo Y; Stebbins GT; Mestre TA; Luo S
    Mov Disord; 2023 Feb; 38(2):342-347. PubMed ID: 36480107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the unified Parkinson's disease rating scale.
    Stebbins GT; Goetz CG; Burn DJ; Jankovic J; Khoo TK; Tilley BC
    Mov Disord; 2013 May; 28(5):668-70. PubMed ID: 23408503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expanded and Independent Spanish Validation of the MDS-Non Motor Rating Scale.
    Cubo E; Luo S; Martínez-Martín P; Stebbins GT; Lin J; Choi D; García-Bustillo A; Mir P; Santos-Garcia D; Serrano-Dueñas M; Rodriguez-Violante M; Singer C;
    Mov Disord Clin Pract; 2023 Apr; 10(4):586-595. PubMed ID: 37071078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of the Hebrew Version of the Unified Dyskinesia Rating Scale.
    Faust-Socher A; Anis S; Kestenbaum M; Shabtai H; Taichman T; Bar David A; Ezra A; Peretz C; Rosenberg A; Brozgol M; Herman T; Stebbins GT; Goetz CG; Martínez-Martín P; Luo ST; Ren X; Giladi N; Gurevich T
    Neuroepidemiology; 2020; 54(4):356-362. PubMed ID: 32541146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of movement disorder society-unified Parkinson's disease rating scale for evaluating effect of subthalamic nucleus deep brain stimulation.
    Yamamoto T; Yamanaka Y; Hirano S; Higuchi Y; Kuwabara S
    Front Neurol; 2022; 13():1042033. PubMed ID: 36686507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between the MDS-UPDRS domains and the health-related quality of life of Parkinson's disease patients.
    Martínez-Martín P; Rodríguez-Blázquez C; Forjaz MJ; Alvarez-Sánchez M; Arakaki T; Bergareche-Yarza A; Chade A; Garretto N; Gershanik O; Kurtis MM; Martínez-Castrillo JC; Mendoza-Rodríguez A; Moore HP; Rodríguez-Violante M; Singer C; Tilley BC; Huang J; Stebbins GT; Goetz CG
    Eur J Neurol; 2014 Mar; 21(3):519-24. PubMed ID: 24447695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Teaching program for the Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale: (MDS-UPDRS).
    Goetz CG; Stebbins GT; Chmura TA; Fahn S; Poewe W; Tanner CM
    Mov Disord; 2010 Jul; 25(9):1190-4. PubMed ID: 20629138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abbreviated MDS-UPDRS for Remote Monitoring in PD Identified Using Exhaustive Computational Search.
    Morinan G; Hauser RA; Schrag A; Tang J; O'Keeffe J; Mds-Nms Scale Development Study Group
    Parkinsons Dis; 2022; 2022():2920255. PubMed ID: 35711334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment Detection and Movement Disorder Society-Unified Parkinson's Disease Rating Scale, Part III Estimation Using Finger Tapping Tasks.
    ZhuParris A; Thijssen E; Elzinga WO; Makai-Bölöni S; Kraaij W; Groeneveld GJ; Doll RJ
    Mov Disord; 2023 Oct; 38(10):1795-1805. PubMed ID: 37401265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does the MDS-UPDRS provide the precision to assess progression in early Parkinson's disease? Learnings from the Parkinson's progression marker initiative cohort.
    Regnault A; Boroojerdi B; Meunier J; Bani M; Morel T; Cano S
    J Neurol; 2019 Aug; 266(8):1927-1936. PubMed ID: 31073716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is the MDS-UPDRS a Good Screening Tool for Detecting Sleep Problems and Daytime Sleepiness in Parkinson's Disease?
    Horváth K; Aschermann Z; Acs P; Bosnyák E; Deli G; Pál E; Janszky J; Faludi B; Késmárki I; Komoly S; Bokor M; Rigó E; Lajtos J; Klivényi P; Dibó G; Vécsei L; Takáts A; Tóth A; Imre P; Nagy F; Herceg M; Kamondi A; Hidasi E; Kovács N
    Parkinsons Dis; 2014; 2014():806169. PubMed ID: 25506041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Movement disorder society unified Parkinson disease rating scale experiences in daily living: longitudinal changes and correlation with other assessments.
    Lang AE; Eberly S; Goetz CG; Stebbins G; Oakes D; Marek K; Ravina B; Tanner CM; Shoulson I;
    Mov Disord; 2013 Dec; 28(14):1980-6. PubMed ID: 24123383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing the relationship between non-motor symptoms and health-related quality of life in Parkinson's disease: a retrospective observational cohort study.
    Ueno T; Kon T; Haga R; Nishijima H; Arai A; Tomiyama M
    Neurol Sci; 2020 Oct; 41(10):2867-2873. PubMed ID: 32328832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.